one of the last companies to stay was pfizer, which had made its name on antibiotics.y the mid-2000s, it had set its sights squarely on the gram-negative problem. >> we thought there was medical need. that's what really matters. and we thought that given our history and being able to develop penicillin, the anti-fungals, you know, antibiotics, that in fact, if we put our minds to it, that we would succeed. but this is a highly risky and unpredictable enterprise. >> narrator: despite the risk, pfizer built a world-class research team in groton, connecticut, and brought in a veteran in gram-negative research: john quinn. >> in 1983, when i finished my training, almost every pharmaceutical company had an antibiotic development team, and by the time i landed at pfizer in 2008, we were really down to three big guys and some smaller companies, bio-techs and so on. and i think all of us felt that, you know, we had a moral obligation to continue to work in this area. there was a pressing clinical need. most companies had abandoned the field and we were still in the game. we we

that's why pfizer was going to be so natural. pfizer will be churning out raises, committed to raising their dividends, the company's so proactive and spun off that animal health division. i like that. second is campbell's soup, um um, not bad. here's a company that won't go bad. it's a serial dividend razor, and i think they have a takeover bid. this looks like quite a bit like heinz. remember that from earlier this year? nothing more consistent than soups and snacks. finally there's dow street. this is a business that keeps taking share and boosting its business. pfizer, campbells, and altria, 2, 3% yielders, and a 5 percenter, all with growth prospects. the yields will go up and that's good for stock prices going here. you know what else, get clocked here, the teleco stocks. that's an opportunity to buy. and i want verizon, which bought the remainder of verizon wireless. the cash flow is there and the interest rate is very well. the growth will be much higher now that it owns all of that wireless business and i don't doubt for

in the surveillance of american citizens now pfizer or the foreign intelligence surveillance act is the piece of legislation that sets the guidelines for the n.s.a.'s bulk collection of foreign intelligence information this is the committee's second open hearing since former government contractor edward snowden leaked detailed information about how the programs operate back in june and a statement a house panel spokesperson said the hearing was in place to quote assess a number of proposals to improve transparency and strengthen privacy protections to further build the confidence of the american public and our nation's pfizer programs so to talk about this hearing and the latest on the n.s.a. i'm joined now by our teeth sam sacks who is live at the capitol sam the hearing was supposed to consider a number of proposals can you talk about what those proposals and tail. good to be with you mary so just to recap the fai's accord is this top secret court that we're told that provides the oversight over a lot of the n.s.a. surveillance programs including the the bulk metadata collection p

of suggestions that were brought up was declassification declassification review process so that pfizer court opinions can be declassified eventually so people can know what the legal rationale is behind certain types of surveillance programs also providing members of congress with more information from the pfizer court to these n.s.a. programs how they work who's affected by them. a special privacy advocate to argue in front of the court on behalf of civil liberties and privacy protections so that so that there's more of an adversarial nature of the court it's not just that the government appealing to two judges there and also and this is kind of that the big deal reform that some members of congress want is changing section two fifteen of the patriot act which underpins the n.s.a. is kind of bulk matted metadata collection program members of congress where we're trying to see if the n.s.a. could go along with a program more like subpoena to subpoenaing telecom communication companies for information on their users rather than just bulk collecting all the data. the government just ball

so just to recap the pfizer court is this top secret court that we're told provides the oversight over a lot of the n.s.a. surveillance programs including the the bulk metadata collection program so the n.s.a. has to go to this court to get a lot of these court orders problem is nobody knows what really goes on inside this court a lot of the court opinions are classified there's only one it's not an adversarial course there's only one are you worried it's from the government and they go to the judge to get information there's no one representing the privacy of the individual who the government is trying to get information about so today's hearing was all about how to bring more transparency to this court in reforms to this court a number of ideas were brought up such as a process for d.c. classifying the court's opinion to give members of congress some more insight into what's what's going on here. there was an idea to install a privacy advocate within the court who would argue on behalf of civil liberties concerns on behalf of privacy against the government lawyer in these top secret

the trade names like nobody's or i don't like that recall many pfizer he just sort of this particular chemical molecule that when you kill your body to fight an infection or out of a disease it really glued to your daughter and you know these bigger countries they come to the factory before the three of them licenses example enough actually we had the u.s. if to get. approval we have german approval we have a pool from greece to be sent to the other two so there was selling a product movies we have people from australia so that it is a system where all regulatory authorities don't take chances they all come and make sure the proposition because there's in place only then the ilo. thank. outside of mumbai's counts are hospitals the patients relatives come for months on end. i have been here for three months. but my son has cancer here on the side. he had surgery we're staying here. but that there was a lump in my chest. i went to get tested and they told me it was cancer and let me go. inside. what should i do all the money i have saved was spent on the trip to come here it is gone. bu

appeal you don't swallow also they trade names like nobody's for i don't know what other company pfizer he just sort of this particular chemical molecule that will help your body to fight infection or out of a disease everyday glittery authority or any of these bigger countries they come to the factory before the three of them licenses example enough actually we had the u.s. if to get. approval we have german approval we have a pool from greece to be sent to the other two so selling a product moody's we have people from australia so that it is a system where all regulatory authorities don't take chances they all come and make sure the proposition because those in place would lead then the ilo. thank. outside of mumbai's counts are hospitals the patients relatives come for months on end. and i have been here for three months. but my son has cancer here on the side. he had surgery we're staying here. but there was a lump in my chest. i went to get tested and they told me it was cancer and let me go. again saturday. what should i do all the money i have saved was spent on the trip to come

pfizer and apple to a pricing the drugs too high in the air in the sixty's in new chemists needed to be needed to set up facilities where we could make the drugs ourselves and these are public sector facilities because the government and they basically sort of not sure an industry into making the drugs that they needed for themselves but of course the moment the industry started to grow other developing countries and u.n. agencies and m.s.f. doctors access to the drugs from the very same source so it benefited of course you know for example india's malaria t.v. program but it also benefited patients outside of india. as a result india became the greatest global power in the production of generic drugs and at the same time protected this population and financial interests. and india is the frog. two of the words of medicines today medicines and you see in today's prices made in india is sold in the us so really new to the soil enough tickets sold in south america and generics probably make up sixty seventy percent no longer going to make up seventy percent of the volume of medicine so

start with pfizer but go down the line. just wondering anything the new law will impact innovation. and it's particularly striking this week in the drug industry that mark, powerhouse and research is cutting back on research but there's some points made up there that suggests there are some incentives for innovation. >> thank you. along really acts as an accelerate. the marketplace has been demanding more value value at ls cost for a while from all of us. and so layoffs in our in the have been happening for a while across the board, most farmers who companies including pfizer have experienced exclusivity loss. the recent event of the merck left is another good example. there are parts of this law that really encourage innovation. the fact that the health insurance marketplaces are competitive, patients have choice. that's something we so through medicare part d. encourage people to look for value. we believe when you look for value they look for valley in their medicines as well as other services. again quality. quality demands, can demand more value. but measures can also go in a w

it pfizer's for wind of the great lakes.if pfizer is for wind off the great lakes. >> the cooler airnd. it is going to get a lot cooler. it will really feel like all outumn. our 7 day temperatures. we have 78 for tomorrow. 81 on thursday and 83 friday. 75 saturday. i would like to say thank you to the american red cross for what they do for the community. this past spring you heard us talking about the used weather radios. these are the ones that provide the warnings in the middle of the night. it turns out a part of the proceeds we are donating to the american red cross. this is made possible by your purchase. i'm happy to welcome to the program today the ceo of the american red cross. thank you for coming in. i want to present you with your part of the proceeds from the is weather radios. $3,000 check. a big thank- you to the american red cross for all that you do. thank you so much. where would we be without the american red cross and this country? >> your support is truly needed. whether it is storms in oklahoma or floods in colorado, the red cross is there to provide shelter. >>

traffic at the harbor tunnel told pfizer running smoothly. that is the latest on traffic pulse 11.to a watery you might run into a watery mess. no customers are without water because of this. if you're water is coming out cloudy, let it run until it clears up. text and drive or you could kill someone. time,river faces jail accused of texting and killing a young dad. jennifer franciotti joins us live to explain. >> police say it was back in march when elizabeth meyers was texting and hit and killed a young father. he was riding a motorcycle at the time. police say evidence supports she was texting behind the wheel. now she is facing six charges including negligent manslaughter by a motor vehicle. no phone call or text is that important. a simulator shows how this driver could easily do something wrong. >> is a bad habit that has touched all four corners of our society. we tend to think this can never happen to me. >> there is a special exception to the law that allows police officers to use cell phones in behind the wheel. that ban has been extended to ensure safety. we are in the s

pfizer, 80% of their profits came from pharma.iversified, they weren't really diversified. and now has a $16 billion market cap and pfizer stock is higher than when they spun that out. there's a lot of pressure on companies that have underperformed to do that. and the question is, are those businesses better served internal to the whole? i think they're a little bit on their back foot because the stock hasn't performed well so there's pressure to do that. pfizer is going one step further now and they're going to separate with three p & ls, one is the innovative core and the other is consumer and -- >> we vary in trying to own businesses with a strategy. we're going to be watching about how they think about the animal health initiative. does that belong in a pharma company or not? >> they'll be pressed on the call at 8:00 this morning. >> we've thought of that. >> people are animals, too, maybe that's what i'm thinking. i don't know. one or the other. i think it's a transitive thing. barbara, thank you. a lot of these companies had

anyway, so you would buy pfizer here? >> i think you could buy pfizer here.oing to see with all of these tech stocks. you see the social messaging services. you see these internet retailers, advertising, online -- you saw the article in the journal yesterday, becky and joe that showed four companies, two of them are going public with no earnings and two are going public with no sales, joe. and this is harkening back to frothier times. >> really? >> we think they'll get frothier, mind you. this party started at 6:00 and it's going to end at midnight and it's probably 10:00. it will get wilder -- >> what time? >> at night. 6:00 in the evening. >> let's do -- >> half way through the -- th this -- >> world series. it's world series. what inning is it? >> you've got -- it's world series, sixth inning. we haven't had the seventh inning stretch yet. it's sixth inning. it will get a little bit more frothy. >> 1,800 on the s&p? >> adam parker's estimate for next year. >> adam parker. you still -- seriously? >> i'm quoting our u.s. equity strategist. >> he's been beari

we have a biotech that is like an ipo that pfizer owned them then spun them off?with us staton market that legator of the world and they call him the godfather of the bator when pfizer marketed it. they are working on the experimental products for the and tolerant market that is a large market. it went public recently less than one year ago and has done fine but not extremely well but you have a product that has a couple million dollar market cap that will quadruple is not successful in will go down it was a successful piece of news. liz: it is higher risk of higher reward that brings us to work day. up when hundred 8% this is a cloud based apps company that helps enterprises we talked about it before but it has not get in any cheaper these days but this is the best of class company management team, they own a small part of that market if they execute if they miss the stock will go lower. liz: something that jumped out 50 percent of the flotilla is shorted. because it could be dangerous anabolic title. >> exactly. this ipo and those are not for the faint of heart

what google has asked is we want to legally tell you how much the pfizer courts ask us for information i think we will be stronger as a country with more transparen with what we're doing. >> what do you make of jeff bezo? >> he's a tremendous american entrepreneur. he figures how to bring in a low price point and he shakes the market up again. he's done it again. this will affect the market. we immediate more tablet competition. these things will do well. >> it is fair to say mobility is one of the biggest game changers, innovation in our lifetime? >> it certainly is and the biggest news in computing. everybody wants a mobile device. lots of different kind of mobile devices. now there's s a new generation applications that are mobile specific. they know where you are. they make suggestions. they helpour life out. if you look at the new kindles there's a bunch of features likk that. gole has similar things. it's just changing everything. >> i talked to dan nile. he's been a good investor. he was pretty negative on google. i want you to hear what he said. it has much to do with motorala.

could start with pfizer to go down the line. the new law will impact innovation, particularly striking this week in the drug industry that mark, powerhouse and researchers is cutting back on research but there's been some points made up there that suggest there are some incentives for innovation. >> thank you. you know, this longer acts as an excellent to change the robbery going on in the market place. the market place has been demanding more value at less cost for a while from all of us. and so layoffs in our in c. have been happening for a while across the board, most pharmaceutical congress including pfizer, exclusivity loss, and with tha that goes wih las vegas to invest back in r&d. but yeah, the recent event of the merck layoff is another good example. there are parts of this law that really encourage innovation. the fact that health insurance marketplaces are competitive, patients have choice, that's something that we saw through medicare part d. encourage people to look for value. we believe when you look for valid to l

the holy grail is regeneralive the process but pfizer is in an early phase of a drug that could boost hearing on an everyday basis. it's too early to say whether it will work but it's a phase 1b study. i think even among the big pharmaceutical companies now, until now hearing loss was under the radar screen. just in the last couple years with population and graphics and the importance of hearing loss and cognition they're recognizing that there may be a pharmacologic target that may be improving hearing similar matally. it sounds far fetch bud going back 20 or 30 years there have been more farfetched -- >> you mean finding a channel and making it conduct effectively. >> well, they either function peripherally to boost the signal or to help with auditory processing. these are early phase drugs that are just being tested for the first time in humans but it's encouraging when you have big pharma coming into the picture in a good way investing in scientists, investing basically the money to basically look for the solutions, there's no reason why it couldn't happen. >> rose: what would you

pfizer -- >> pfizer started to pay for the company expansion in 2012 -- 2010. all of that notwithstanding, we believe you did the right thing. and that is difficult to do, insurance helps bring you time, but in order to stay on and in him -- and have an enhanced regimen, you need the access to insurance and reforms that are in place that means that they cannot be taken away. all important through medicaid and the health insurance exchange, bringing new people into the marketplace. the revenue question does not offset the fees, but it again goes into the right place. >> not just coverage expansion, but they are reducing cost. pharmaceuticals are effective in avoiding more expensive health interventions. would they not consider the cost of medicines? they are known to reduce other and they can really prove who -- really prove outcome and prevention. parts of it being effective are that you do not just get your and we look at the benefits coming out in the design. or with your free cancer screening on the formula of your >> you all talked about how you would be wo

could start with pfizer but go down the line.laughter] i was wondering how you think the new law will impact innovation. it's particularly striking this week in the drug industry that merk, hour house, and research is cutting back on research. there's been some points made up there that suggests there are some incentives for innovation. >> thank you. so, you know, this law really acts as an -- axel rabbits. they are demanding more value at less cost for awhile from all of us. and so layoffs in indeed have been happening for awhile. across the board most of the pharmaceutical companies including pfizer have -- exclusivity loss. with that loss goes with loss of revenue to reinvest in r&d. the recent event of the layoff is another good example. there are part of the through a encourage innovation. the fact that the held insurance marketplaces are competitive. patients have choice, that's something we saw through medicare part d. encourage people it look for value. they look for value in the medicine as well as other services. and qu

i could start with pfizer but go down the line -- i'm wondering how you think the new law will impact innovation. it is particularly striking this week in the drug industry that cutting backouse, on research, but there have been some points made up their that there are some incentives for innovation. >> thank you. it acts as an accelerant to change is already going on in the marketplace. the marketplace has demanding more value at less cost for a while from all of us. has beenn r&d happening for a while across the board. most pharmaceutical companies -- yeah, thezer recent event of the merck layoff is another good example. there are parts of this law that really encourage innovation. the fact that the health insurance marketplaces are patients haveopa choice. that is something we saw through medicare part d. it encourages people to look for value. when they look for value, they look for value in their medicines as well as other services. demand demand's -- can more value. measures can also go in a way that are shortsighted and purely cost based. inbelieve if the measures the system co

ten dow stocks, multiyear highs in october. 3m, procter & gamble, american express, pfizer, visa, those are five of them. we'll tell you the other big five. that is a really readable chart right there. you can see that right there. we'll tell you the other five after this break. happy halloween, martha stewart. >> boo! >> the homemaking guru is on deck. still ahead. there she is. looking good. tdd#: 1-800-345-2550 trading inspires your life. tdd#: 1-800-345-2550 life inspires your trading. tdd#: 1-800-345-2550 where others see fads... tdd#: 1-800-345-2550 ...you see opportunities. tdd#: 1-800-345-2550 at schwab, we're here to help tdd#: 1-800-345-2550 turn inspiration into action. tdd#: 1-800-345-2550 we have intuitive platforms tdd#: 1-800-345-2550 to help you discover what's trending. tdd#: 1-800-345-2550 and seasoned market experts to help sharpen your instincts. tdd#: 1-800-345-2550 so you can take charge tdd#: 1-800-345-2550 of your trading. >>> welcome back. i'm sharon epperson at the nymex. gold futures about to close right now. down about $25 from yesterday's close. about 130. o

just to recap, the pfizer court is this top-secret court -- this fisa court is this top-secret court that provides the oversight over the nsa. they have to go to this court to get a lot of these court orders. the problem is that nobody really knows what goes i inside. the opinions are classified. there's only one arguer and it is from the government and there is no one representing the privacy of the individual from whom the government is turned to get information from. so today was about getting more transparency and a number of ideas were brought up, such as a process for declassifying the court's opinion to give members of congress some idea what is going on here. and there is an idea to install it privacy advocate within the court who would argue on behalf of civil liberties. there is another proposal on the table to restrict section 215 of the patriot act, the is this records provision which nsa, which the court has given the nsa the authority to scoop up all of our phone metadata that the nsa -- that the romance have been revealed -- that the programs have been revealed by edwa

pfizer posted earnings that beat estimates, but revenues at the world's largest drug maker slipped 2% due to a loss of patents on its best sellers including lipitor. goodyear tire rolled in with a 51% profit gain, but the companies sales numbers were below analysts expecations causing that stock to drop nearly 6% shares of nokia jumped 10% after the telecom firm issued an upbeat forecast. and earnings fell 21% for archer daniels midland. adm lost money last year because of the drought, but expects this year's bumper crop of corn will sweeten sales numbers. today is testimony day for heatlh and human services secretary kathleen sebelius. she is scheduled to testify before a house oversight panel about the glitches american's are encountering as they attempt to shop for health insurance at healthcare.gov. yesterday... mariylnn tavenner-- head of the u.s. centers for medicare and medicaide services apologized during her testimony but says the site is operating. tavenner says enrollment numbers will be available mid november. house speaker john boehner continues to call for a delay in the

eleven many of these reform proposals run the risk of recreating the type of cumbersome over lawyer pfizer regime that proved so inadequate in the wake of nine eleven one incident was called nine eleven that should never happen again well asia times correspondent pepe escobar thinks this approach cannot be justified because it's mainly intelligence on the ground not electronic surveillance that helps prevent terrorism. nowadays we have this electronic mule filled the lism. built in the george orwell orwellian optical complex where the piece of it has a start it's always nine eleven justify buying on virtually every citizen in the world from sub-saharan africa to western china this is completely absurd because they are not for any loss because of electronic surveillance on top of it we cannot believe it is seeing a general keith alexander chief of n.s.a. says he is an orwellian functionary you know defending you pretty realistic myth of all the g. fact it's complete it's beyond surrealism because it doesn't make sense if you don't have the ground tell you cannot fight what was called the wa

when did pfizer is as the returning southerly flow brings warm air into the plains states. 60s today,onight we go down to the 40's away from the like.lake 6. use with '70s and land. sick. steve's with '70and land. tonigh. high temperature of 59. the wind will let up and become a very below 43. tomorrow sunny and mild in the afternoon. 72 assault went 5-15. wednesday sunny and mild. not a bad forecast. i cannot get over the fact that we're running four degrees warmer than last year. >> we have some beautiful weather. >> time for today's tr[ indistinct conversations ] [ male announcer ] when you wear dentures you may not know it, but your mouth is under attack. food particles infiltrate and bacteria proliferate. ♪ protect your mouth, with fixodent. the adhesive helps create a food seal defense for a clean mouth and kills bacteria for fresh breath. ♪ fixodent, and forget it. folks have suffered from frequent heartburn. but getting heartburn and then treating day after day is a thing of the past. block the acid with prilosec otc, and don't get heartburn in the first place. [ male announce

google yahoo facebook they've been fighting requests via the pfizer court they've been fighting requests like the ones that i received. the fact is they've been losing. five days of government shutdown have done little to cool tempos in washington where republican and democratic lawmakers are bickering over budget technicalities what's worth it doesn't look like the crisis will end anytime soon and could even get a whole lot worse by the seventeenth that's when lawmakers the have to raise america's the debt ceiling in order to pay off debts otherwise that means default replications of which could be horrendous for the world economy currently hundreds of thousands of state workers have been laid off in the u.s. with organizations as big as the n.s.a. nasa forced to wind down operations george abbey who used to oversee the international space station for houston told us there will be long lasting aftershocks missions that are coming up in say four or five or six months fairly critical motions are immersions that robotic rights are going to the planets they have launch windows that have to

google yahoo facebook they've been fighting requests via the pfizer court they've been fighting requests like the ones that i received. the fact is they've been losing political deadlock in the u.s. raising the country's debt ceiling shows no signs of easing ahead of a decision deadline in less than a fortnight according to the international monetary fund chief of the crisis is now threatening the global economy the u.s. treasury department agrees with the diet folks possible default could drag america into a recession or some the one in two thousand and eight some of the organizations considered to be nonessential for government operations are already feeling the pinch george abbey you see the international space station for nasa told us they will be long lasting aftershocks. there are missions that are coming up in say four or five or six months fairly critical missions or missions that are robotic flights that are going to the planets they have launch windows that have to be maintained and if their workers are furloughed that work and being done and so there is going to be an effect d

google yahoo facebook they've been fighting requests via the pfizer court they've been fighting requests like the ones that i received. the fact is they've been losing. five days of government shutdown and have done little to cool tempers in washington where republican and democrat will make has a big of a budget technicality and what's worse it doesn't look like the crisis will end anytime soon and could even get a whole lot worse by october the seventeenth or not that's one lawmaker is the have a to raise america's debt ceiling in order to pay our debts otherwise that means default the repercussions of which could be horrendous while the world economy currently hundreds of thousands of state workers have been laid off in the u.s. with organizations as big as nasa forced to wind down operations who used to oversee the international space station from houston told us that there will be a long lasting off the shocks. there are missions that are coming up in say four or five or six months early critical motions are immersions a. lot of whites are going to the planets they have launch windo

eleven many of these reform proposals run the risk of recreating the type of cumbersome over lawyer pfizer regime that proved so inadequate in the wake of nine eleven one incident was called nine eleven that should never happen again. the attitude of the u.s. intelligence community indicates a reluctance to reforms as american interest political analyst eric draitser. to intrust the scene bureaucrats like clapper and others who have been caught lying publicly on the record to congress and to other policymakers and officials about the nature of these programs about what the united states is doing about its very operations in the most public sense of the word and so we are to intrust these people with some kind of an internal review it is laughable it is just about as laughable as wall street banks regulating themselves. on the techniques used by the n.s.a. are being revealed as a reporter and the washington post shows the agency has been harvesting huge amounts of data from google and yahoo by breaking into that communication links and they say leaked a sketch from an internal presentation